Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Pluronic F127-based Ocular Delivery System Containing Biodegradable Polyisobutylcyanoacrylate Nanocapsules Of Pilocarpine.

S. D. Desai, J. Blanchard
Published 2000 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The objectives of our study were to prepare a biodegradable polyisobutylcyanoacrylate (PIBCA) colloidal particulate system of pilocarpine, to incorporate it into a Pluronic F127(PF127)-based gel delivery system, and to evaluate its ability to prolong the release of pilocarpine. Polyisobutylcyanoacrylate nanocapsules (PIBCA-NC) of pilocarpine were prepared by interfacial polymerization. Physicochemical characterization of the colloidal dispersion of PIBCA-NC of pilocarpine was performed by measuring drug loading, particle size analysis, and scanning electron microscopy. Results indicated that approximately 13.5% of pilocarpine was loaded onto the PIBCA-NC, the nanocapsules ranged from 370 to 460 nm, the distribution was narrow, and there was no significant effect of stirring speed on particle size. The PIBCA-NC dispersion of 1% pilocarpine alone (I) and after incorporation into the Pluronic F127 gel delivery system (II) were compared against 1% pilocarpine incorporated into a PF127 gel containing 5% methylcellulose (PF127MC) alone (III) by measuring the miotic response in the albino rabbit eye. Statistical analysis indicated a rank-order for both the duration and intensity of miosis of II > III >> I, with all differences being significant (p < 0.05). Thus, it appears that II increases the contact time of pilocarpine with the absorbing tissue in the eye, thereby improving ocular bioavailability. The PIBCA-NC of pilocarpine dispersed in the PF127MC gel delivery system has considerable potential for achieving a prolonged delivery for such drugs as pilocarpine and other more hydrophobic drugs.
This paper references
10.1111/j.2042-7158.1986.tb04547.x
Polyalkyl cyanoacrylate nanocapsules
M. El-Samaligy (1986)
Pharmacokinetic evaluation of indomethacin nanocapsules.
V. Andrieu (1989)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.1016/0378-5173(89)90334-7
Distribution of poly-hexyl-2-cyano-[3-14C]acrylate nanoparticles in healthy and chronically inflamed rabbit eyes
R. Diepold (1989)
10.1016/0378-5173(85)90007-9
Ocular disposition of poly-hexyl-2-cyano[3-14C]acrylate nanoparticles in the albino rabbit
R. Wood (1985)
10.1002/JPS.2600690222
Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles.
P. Couvreur (1980)
10.1093/CHROMSCI/30.4.149
A simplified and rapid high-performance liquid chromatographic assay for pilocarpine hydrochloride
S. D. Desai (1992)
10.1002/JPS.2600710717
Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.
P. Couvreur (1982)
10.1016/0378-5173(87)90050-0
A γ-scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles
P. Fitzgerald (1987)
10.1016/0014-5793(77)80717-5
Nanocapsules: A new type of lysosomotropic carrier
P. Couvreur (1977)
10.1016/0378-5173(80)90097-6
Tissue Distribution of [actinomycin-h-3 D Adsorbed On Polybutylcyanoacrylate Nanoparticles
B. Kante (1980)
10.1111/j.2042-7158.1979.tb13510.x
Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties
P. Couvreur (1979)
10.1097/00007691-199007000-00017
Comparison of Ultrafiltration Devices for Assessing Theophylline Protein Binding
J. Blanchard (1990)
10.1002/JBM.820060609
Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns.
I. R. Schmolka (1972)
10.1111/J.1768-322X.1987.TB00571.X
Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine
M. Aprahamian (1987)
10.1016/0378-5173(86)90236-X
Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules
N. A. K. Fallouh (1986)
10.1002/JPS.2600681215
Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum.
P. Couvreur (1979)
10.1016/0378-5173(83)90133-3
Polybutylcyanoacrylate nanoparticles for the delivery of [75Se]norcholestenol
J. Kreuter (1983)
10.1016/0378-5173(90)90248-3
Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations
L. Marchal-Heussler (1990)
10.1016/0378-5173(86)90053-0
Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles
T. Harmia (1986)
Drug-loaded nanoparticles : preparation methods and drug targeting issues
E. Allémann (1993)



This paper is referenced by
Poly(alkycyanoacrylate) nanoparticlesforenhanced deliveryoftherapeutics-isthere realpotential?
Anja Graf (2009)
10.1002/3527600035.BPOL9021
Biodegradation of Poly(alkylcyanoacrylates)
C. Vauthier (2002)
10.1002/9781118444726.CH6
Polymeric Drug Delivery Systems for Encapsulating Hydrophobic Drugs
D. Fischer (2013)
10.1016/j.ijpharm.2013.07.057
A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
J. Li (2013)
10.1016/J.ADDR.2005.07.005
The use of mucoadhesive polymers in ocular drug delivery.
A. Ludwig (2005)
10.1016/J.EJPB.2006.12.013
Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design.
S. Chopra (2007)
Polymer Gels as Pharmaceutical Dosage Forms Rheological Performance and Physicochemical Interactions at the Gel-Mucus Interface for Formulations Intended for Mucosal Drug Delivery
Till hela min familj (2003)
10.1016/j.colsurfb.2011.08.022
Gel formulations containing catanionic vesicles composed of alprenolol and SDS: effects of drug release and skin penetration on aggregate structure.
Noel Dew (2012)
10.1201/B11035-4
Nanocapsules as Carriers for the Transport and Targeted Delivery of Bioactive Molecules
P. Hervella (2011)
10.1201/B10846-10
Transmucosal and Ocular Drug Delivery
Vasant V. Ranade (2011)
10.11606/T.9.2016.tde-16032016-101157
Desenvolvimento de nanopartículas de poli (n-butil-cianoacrilato) com zidovudina revestidas por ácido hialurônico para veiculação em gel de uso transdérmico
Marcelo Guimarães (2015)
10.1007/S00396-003-1027-6
Evaluation of the surface properties of dextran-coated poly(isobutylcyanoacrylate) nanoparticles by spin-labelling coupled with electron resonance spectroscopy
C. Chauvierre (2004)
In-Situ Gelling System : A Novel Approach for Ocular Drug Delivery
Gourav Rajoria (2012)
10.1006/JCIS.2001.8182
Controlled drug release from gels using lipophilic interactions of charged substances with surfactants and polymers.
Mattias Paulsson (2002)
Pharmacology and antinociception of a sustained-released butorphanol – poloxamer 407 formulation in Amazon parrots
Delphine Laniesse (2016)
10.1080/10717540802035251
Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation.
I. Alsarra (2008)
10.1039/B607437E
Thermally-induced glass formation from hydrogel nanoparticles.
D. Missirlis (2006)
DEVELOPMENT AND EVALUATION OF LIPOSOMAL MUCOADHESIVE GEL FOR NASAL DELIVERY OF ACYCLOVIR
Amel Y. Hamed (2008)
10.1007/s11095-006-9104-4
A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics
G. Dumortier (2006)
10.1016/j.ijpharm.2011.09.002
Characterization of a pseudo ternary phase diagram of poloxamer 407 systems for potential application of 5-aminolevulinic acid in photodynamic therapy.
Carlos van Hemelrijck (2011)
10.1089/TEN.2004.10.1566
Three-dimensional bioassembly tool for generating viable tissue-engineered constructs.
C. M. Smith (2004)
10.1016/j.jconrel.2008.12.018
Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
R. C. Nagarwal (2009)
10.1023/A:1013086632302
Controlled Drug Release from Gels Using Surfactant Aggregates. II. Vesicles Formed from Mixtures of Amphiphilic Drugs and Oppositely Charged Surfactants
Mattias Paulsson (2004)
10.2174/1874464810801030186
Cyano Acrylate Polymers in Medical Applications
R. Pawar (2008)
Nanoparticulate Drug Delivery Systems
Jaya Raja Kumar Kalaimani (2016)
10.1002/9781118774205.CH1
Stimuli‐Responsive Smart Nanoparticles for Biomedical Application
A. De (2014)
10.1002/JPS.10227
Ocular tolerability of Eudragit RS100 and RL100 nanosuspensions as carriers for ophthalmic controlled drug delivery.
R. Pignatello (2002)
10.1016/S0378-5173(02)00232-6
Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions.
J. Chang (2002)
10.1080/10611860701603372
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery
C. Vauthier (2007)
A Direct-Write Three-Dimensional Bioassembly Tool for Regenerative Medicine
C. Smith (2005)
10.1007/978-3-319-12478-0_6
Polymers in Ophthalmology
J. A. Calles (2015)
10.22377/AJP.V2I1.157
Polymers used in ocular dosage form and drug delivery systems
Vijay D. Wagh (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar